Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03055728 · ClinicalTrials.gov registry record
Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis
A clinical trial, sponsored by Georgetown University.
- Completed
- Registry status
- 600
- Enrollment target
NCT03055728: Completed study, sponsored by Georgetown University.
NCT03055728 is a clinical trial that has completed, run by Georgetown University. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03055728 has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the rapid antigen detection test for Group A streptococcal pharyngitis diagnosis might yield higher rates of false positive results in patients who have been treated for GAS pharyngitis within 28 days of the test.
Primary Outcome
The primary objective is to use rapid antigen test results to compare the sensitivity and specificity of rapid antigen testing in children with symptoms of pharyngitis with and without a recent history of Group A streptococcus pharyngitis.
Interventions
- DIAGNOSTIC_TEST Rapid strep antigen detection test
- DIAGNOSTIC_TEST throat culture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2013-05-09 |
| Est. Completion | 2018-01-16 |
What the finished NCT03055728 record still lists
NCT03055728 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Rapid strep antigen detection test is the first listed.
NCT03055728 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03055728 about?
NCT03055728 is a clinical study titled "Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis". The purpose of this study is to determine if the rapid antigen detection test for Group A streptococcal pharyngitis diagnosis might yield higher rates of false positive results in patients who have been treated for GAS pharyngitis within 28 days of the test.
What is the current status of trial NCT03055728?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2013-05-09. Estimated completion is 2018-01-16.
What interventions are being tested in trial NCT03055728?
The interventions under investigation include: Rapid strep antigen detection test (DIAGNOSTIC_TEST), throat culture (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03055728?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI